SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-22-003125
Filing Date
2022-11-10
Accepted
2022-11-10 16:00:38
Documents
55
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mtryu-20220930x10q.htm   iXBRL 10-Q 995209
2 EX-31.1 mtryu-20220930xex31d1.htm EX-31.1 10724
3 EX-31.2 mtryu-20220930xex31d2.htm EX-31.2 10985
4 EX-32.1 mtryu-20220930xex32d1.htm EX-32.1 5383
5 EX-32.2 mtryu-20220930xex32d2.htm EX-32.2 5389
  Complete submission text file 0001410578-22-003125.txt   4903108

Data Files

Seq Description Document Type Size
6 EX-101.SCH mtryu-20220930.xsd EX-101.SCH 53641
7 EX-101.CAL mtryu-20220930_cal.xml EX-101.CAL 21547
8 EX-101.DEF mtryu-20220930_def.xml EX-101.DEF 221678
9 EX-101.LAB mtryu-20220930_lab.xml EX-101.LAB 354515
10 EX-101.PRE mtryu-20220930_pre.xml EX-101.PRE 300748
49 EXTRACTED XBRL INSTANCE DOCUMENT mtryu-20220930x10q_htm.xml XML 747708
Mailing Address 17 STATE STREET 21ST FLOOR NEW YORK NY 10004
Business Address 17 STATE STREET 21ST FLOOR NEW YORK NY 10004 917-267-0216
Monterey Bio Acquisition Corp (Filer) CIK: 0001860663 (see all company filings)

IRS No.: 852204842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40861 | Film No.: 221376865
SIC: 6770 Blank Checks